Financials data is unavailable for this security.
View more
Year on year Cosmos Pharmaceutical Corp had little change in net income (from 23.80bn to 24.45bn) despite revenues that grew 16.59% from 827.70bn to 964.99bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 79.62% to 80.49%.
| Gross margin | 19.88% |
|---|---|
| Net profit margin | 2.65% |
| Operating margin | 3.38% |
| Return on assets | 5.67% |
|---|---|
| Return on equity | 11.53% |
| Return on investment | 10.42% |
More ▼
Cash flow in JPYView more
In 2024, Cosmos Pharmaceutical Corp increased its cash reserves by 13.88%, or 6.37bn. The company earned 55.18bn from its operations for a Cash Flow Margin of 5.72%. In addition the company generated 8.53bn cash from financing while 57.33bn was spent on investing.
| Cash flow per share | 588.16 |
|---|---|
| Price/Cash flow per share | 11.53 |
| Book value per share | 2,992.83 |
|---|---|
| Tangible book value per share | 2,986.85 |
More ▼
Balance sheet in JPYView more
| Current ratio | 0.7213 |
|---|---|
| Quick ratio | 0.3209 |
| Total debt/total equity | 0.1131 |
|---|---|
| Total debt/total capital | 0.1016 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 20.00% and 2.71%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Grocery) industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.62% |
|---|---|
| Div growth rate (5 year) | 19.14% |
| Payout ratio (TTM) | 18.22% |
| EPS growth(5 years) | 4.96 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 9.43 |
More ▼
